This clinical-stage biotech develops monoclonal antibody therapies targeting psoriasis and other immunology indications.

In this video, Eingun James Song, MD, FAAD, discusses innovations in psoriasis and the differences in efficacy and safety ...

In a recent review published in Signal Transduction and Targeted Therapy, researchers reviewed existing data on psoriasis etiopathogenesis and treatment. Psoriasis is a prevalent, chronic, ...

At the recent American Academy of Dermatology annual meeting, experts emphasized that psoriasis is more than a skin disease - ...

A new study has found that biologic class and treatment sequencing influences psoriatic arthritis risk in patients with ...

More than eight million people in the United States have the autoimmune skin condition known as psoriasis, according to the National Psoriasis Foundation. Psoriasis is a chronic condition. There’s no ...

Psoriasis causes your body to make new skin cells too quickly. These cells tend to pile up and form spots, bumps, and thick scaly patches called plaques that can be uncomfortable. Scientists think ...

Each August, Psoriasis Awareness Month shines a light on a condition affecting millions worldwide. This special time helps people understand psoriasis better. It also builds vital support for ...

Psoriasis is an autoimmune disorder that causes scaly, red, and often itchy patches on the skin. The condition affects millions of Americans — including these celebrities Kardashian West revealed her ...